Campbell & Co Investment Adviser’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,112
Closed -$1.43M 1212
2025
Q3
$1.43M Sell
26,112
-2,412
-8% -$121K 0.11% 286
2025
Q2
$1.52M Buy
+28,524
New +$1.45M 0.1% 334
2024
Q1
Sell
-7,219
Closed -$534K 1181
2023
Q4
$534K Sell
7,219
-19,797
-73% -$1.3M 0.05% 676
2023
Q3
$1.84M Buy
27,016
+23,808
+742% +$2.02M 0.22% 108
2023
Q2
$301K Buy
+3,208
New +$250K 0.05% 663
2022
Q4
Sell
-11,567
Closed -$376K 832
2022
Q3
$376K Buy
11,567
+2,385
+26% +$98.3K 0.09% 405
2022
Q2
$362K Buy
+9,182
New +$491K 0.1% 393
2021
Q4
Sell
-2,455
Closed -$234K 661
2021
Q3
$234K Sell
2,455
-550
-18% -$58.1K 0.08% 461
2021
Q2
$374K Buy
+3,005
New +$359K 0.15% 241
2019
Q4
Sell
-3,953
Closed -$357K 698
2019
Q3
$357K Buy
+3,953
New +$450K 0.13% 305
2017
Q1
Sell
-13,100
Closed -$175K 171
2016
Q4
$175K Buy
+13,100
New +$211K 0.54% 101

Other funds holding EXAS

Campbell & Co Investment Adviser's EXAS Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 26,112 shares — an estimated $1.43M sold.

Campbell & Co Investment Adviser first reported a position in EXAS in Q4 2016 and held it in 11 quarters. The position peaked at $1.84M in Q3 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Campbell & Co Investment Adviser reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 26,112 Exact Sciences shares in Q4 2025, an estimated $1.43M.
  • Campbell & Co Investment Adviser first reported a position in Exact Sciences in Q4 2016 and held it in 11 quarters.
  • Campbell & Co Investment Adviser's Exact Sciences position peaked at $1.84M in Q3 2023.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.